Skip to content

The Edge of the Cyber World See the latest

Technology

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

The Danish company and AbbVie said their Epkinly drug helped extend the time patients with a common type of lymphoma lived.

Source: WSJ Technology